World Journal of Gastrointestinal Oncology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Zhou DQ, Liu JY, Zhao F, Zhang J, Liu LL, Jia JR, Cao ZH. Risk factors for hepatocellular carcinoma in cirrhosis: A comprehensive analysis from a decade-long study. World J Gastrointest Oncol 2024; 16(12): 4625-4635 [PMID: 39678801 DOI: 10.4251/wjgo.v16.i12.4625]
URL:	https://www.wjgnet.com/1948-5204/full/v16/i12/4625.htm

(129) (114) (0) (0) (0) (12) (1) (3852) (6)

Number	Citing Articles
1	Xiaojia Guo, Yuanyuan Xie, Rongmin Qian, Jing Li, Junling Shi, Qingsheng Huang, Dongyan Shao. Mechanical microenvironment and its role in hepatocellular carcinoma oncogenesis and progression. Critical Reviews in Oncology/Hematology 2026; 218 doi: 10.1016/j.critrevonc.2025.105099
2	Jing Zeng, Ganhua Zeng. Comment on “Posttreatment FIB-4 score change predicts hepatocellular carcinoma in chronic hepatitis C patients”. Journal of the Formosan Medical Association 2026; 125(2) doi: 10.1016/j.jfma.2025.04.001
3	Hitomi Takada, Nobuharu Tamaki, Hironori Ochi, Nami Mori, Keiji Tsuji, Toshifumi Tada, Shinichiro Nakamura, Junichi Toshimori, Naoki Yoshioka, Hirotaka Arai, Hideki Fujii, Chitomi Hasebe, Toshimitsu Murohisa, Eisuke Okamoto, Masahiko Kondo, Hiroyuki Marusawa, Naohito Urawa, Takuto Yoshioka, Hideo Yoshida, Ryoichi Narita, Takehiro Akahane, Atsunori Kusakabe, Michiko Nonogi, Ryosuke Imado, Yasushi Uchida, Takashi Sato, Keisuke Yokohama, Yoshihito Kubotsu, Toru Ishii, Namiki Izumi, Masayuki Kurosaki. Sofosbuvir/Velpatasvir in Chronic Hepatitis C, Compensated and Decompensated Cirrhosis, and Retreatment Settings. Internal Medicine 2026; doi: 10.2169/internalmedicine.6497-25
4	Zhou Liu, Zhong-Bin Li, Yun Zhao, Chang Guo, Meng-Qi Sun, Yi-Zhe Zhang, Jia-Min Cheng, Yi-Ming Fu, Yin-Ying Lu, Dong Ji, Xiao-Xia Niu, Jian-Jun Wang. The Impact of Blood Ammonia After Interventional Therapy on the Prognosis of Patients with Unresectable Hepatocellular Carcinoma. iLIVER 2026; doi: 10.1016/j.iliver.2026.100251
5	Ronald Blanco Montecino, Nehemias Guevara Rodriguez, Noemy Coreas, Daniel Mendoza-Quispe, Yassine Kilani, Syeda Ashna Fatima Kamal, Kamran Qureshi, John M Richart. Tyrosine kinase inhibitors after progression on atezolizumab-bevacizumab in advanced hepatocellular carcinoma: A systematic review and meta-analysis. World Journal of Hepatology 2026; 18(6): 121656 doi: 10.4254/wjh.121656 Abstract(27) \| Core Tip(26) \| Full Article(HTML)(112) \| Full Article (PDF)-11984K(17) \| Full Article with Cover (PDF)-12247K(9) \| Full Article (XML)-148K(8) \| Audio-581K(0) \| Peer-Review Report-201K(10) \| Answering Reviewers-219K(11) \| Supplementary Material-3033K(11) \| Times Cited (0) \| Total Visits (177) \| Open
6	Varun Mehta, Manjeet Kumar Goyal, Yogesh Kumar Gupta, Abhinav Gupta, Manisha Khubber, Tanisha Sehgal, Prabhav Mehta, Omesh Goyal. Liver stiffness at baseline as a marker of hepatocellular carcinoma in cirrhosis: A matched analysis. World Journal of Gastrointestinal Pathophysiology 2026; 17(2): 120603 doi: 10.4291/wjgp.v17.i2.120603 Abstract(24) \| Core Tip(21) \| Full Article(HTML)(75) \| Full Article (PDF)-738K(16) \| Full Article with Cover (PDF)-2373K(7) \| Full Article (XML)-101K(7) \| Audio-474K(4) \| Peer-Review Report-251K(9) \| Answering Reviewers-247K(11) \| Times Cited (0) \| Total Visits (145) \| Open

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.